Skip to main content
BB Biotech AG logo

BB Biotech AG — Investor Relations & Filings

Ticker · BION ISIN · CH0027659793 LEI · 391200MBZQNPFHIVKO34 SW Financial and insurance activities
Filings indexed 267 across all filing types
Latest filing 2005-07-28 Interim / Quarterly Rep…
Country CH Switzerland
Listing SW BION

BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Q2 Report 2005
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report as at June 30, 2005' for BB BIOTECH AG. It contains comprehensive financial data, including a consolidated semi-annual statement, key figures, portfolio details, and explanatory notes. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2005
2005-07-28 English
Q1 Report 2005
Interim / Quarterly Report
2005-04-28 English
3-Monatsbericht 2005
Interim / Quarterly Report
2005-04-28 German
Annual Report 2004
Annual Report
2005-03-10 German
Q3 Report 2004
Interim / Quarterly Report
2004-10-28 German
Q2 Report 2004
Interim / Quarterly Report
2004-08-11 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.